Meei‐Yun Lin

459 total citations
10 papers, 328 citations indexed

About

Meei‐Yun Lin is a scholar working on Infectious Diseases, Immunology and Health. According to data from OpenAlex, Meei‐Yun Lin has authored 10 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Immunology and 3 papers in Health. Recurrent topics in Meei‐Yun Lin's work include SARS-CoV-2 and COVID-19 Research (6 papers), Immune Cell Function and Interaction (4 papers) and Vaccine Coverage and Hesitancy (3 papers). Meei‐Yun Lin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Immune Cell Function and Interaction (4 papers) and Vaccine Coverage and Hesitancy (3 papers). Meei‐Yun Lin collaborates with scholars based in United States, Taiwan and Japan. Meei‐Yun Lin's co-authors include Raymond M. Welsh, Michael A. Brehm, James M. McNally, Liisa K. Selin, Steven M. Varga, Barbara L. Lohman, Chia-En Lien, Dawne M. Page, Tatsuro Irimura and Thandi M. Onami and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Clinical Infectious Diseases.

In The Last Decade

Meei‐Yun Lin

10 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meei‐Yun Lin United States 6 223 84 73 44 23 10 328
Candie Joly France 7 116 0.5× 98 1.2× 50 0.7× 54 1.2× 16 0.7× 10 240
Mary Giffear United States 3 185 0.8× 62 0.7× 108 1.5× 79 1.8× 52 2.3× 5 307
Caroline L. Ashley Australia 9 140 0.6× 93 1.1× 91 1.2× 100 2.3× 18 0.8× 15 300
Arwa Qaqish Jordan 9 145 0.7× 108 1.3× 62 0.8× 47 1.1× 33 1.4× 20 297
Ane Ogbe United Kingdom 9 188 0.8× 117 1.4× 44 0.6× 66 1.5× 29 1.3× 16 337
Henry J. Sutton United States 7 212 1.0× 37 0.4× 48 0.7× 50 1.1× 19 0.8× 10 318
Stella E. van Trierum Netherlands 8 246 1.1× 88 1.0× 308 4.2× 87 2.0× 26 1.1× 9 441
Rafi Ahmed United States 4 131 0.6× 181 2.2× 73 1.0× 27 0.6× 27 1.2× 7 317
Ludivine Grzelak France 7 100 0.4× 194 2.3× 28 0.4× 54 1.2× 25 1.1× 10 298
Dennis Lapuente Germany 12 139 0.6× 117 1.4× 93 1.3× 74 1.7× 33 1.4× 22 286

Countries citing papers authored by Meei‐Yun Lin

Since Specialization
Citations

This map shows the geographic impact of Meei‐Yun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meei‐Yun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meei‐Yun Lin more than expected).

Fields of papers citing papers by Meei‐Yun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meei‐Yun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meei‐Yun Lin. The network helps show where Meei‐Yun Lin may publish in the future.

Co-authorship network of co-authors of Meei‐Yun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Meei‐Yun Lin. A scholar is included among the top collaborators of Meei‐Yun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meei‐Yun Lin. Meei‐Yun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Luke Tzu-Chi, Cheng‐Hsun Chiu, Nan‐Chang Chiu, et al.. (2022). Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial. npj Vaccines. 7(1). 165–165. 10 indexed citations
2.
Lin, Yi‐Jiun, Meei‐Yun Lin, Luke Tzu-Chi Liu, et al.. (2022). Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine. Scientific Reports. 12(1). 11369–11369. 5 indexed citations
3.
Ganesan, Shyamala, Charles Chen, Chia-En Lien, et al.. (2022). Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice. PLoS ONE. 17(11). e0272594–e0272594. 2 indexed citations
4.
Kuo, Tsun‐Yung, Chia-En Lien, Yi‐Jiun Lin, et al.. (2022). Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P. The Journal of Infectious Diseases. 226(9). 1562–1567. 2 indexed citations
5.
6.
Lien, Chia-En, Tsun‐Yung Kuo, Yi‐Jiun Lin, et al.. (2021). Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern. Clinical Infectious Diseases. 74(11). 1899–1905. 11 indexed citations
7.
Onami, Thandi M., Meei‐Yun Lin, Dawne M. Page, et al.. (2002). Generation of Mice Deficient for Macrophage Galactose- and N-Acetylgalactosamine-Specific Lectin: Limited Role in Lymphoid and Erythroid Homeostasis and Evidence for Multiple Lectins. Molecular and Cellular Biology. 22(18). 6661–6661. 1 indexed citations
8.
Onami, Thandi M., Meei‐Yun Lin, Dawne M. Page, et al.. (2002). Generation of Mice Deficient for Macrophage Galactose- and N-Acetylgalactosamine-Specific Lectin: Limited Role in Lymphoid and Erythroid Homeostasis and Evidence for Multiple Lectins. Molecular and Cellular Biology. 22(14). 5173–5181. 37 indexed citations
9.
McNally, James M., et al.. (2001). Attrition of Bystander CD8 T Cells during Virus-Induced T-Cell and Interferon Responses. Journal of Virology. 75(13). 5965–5976. 170 indexed citations
10.
Welsh, Raymond M., et al.. (1997). αβ and γδ T‐cell networks and their roles in natural resistance to viral infections. Immunological Reviews. 159(1). 79–93. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Candie Joly Breakdown of academic impact, for papers by Mary Giffear Breakdown of academic impact, for papers by Caroline L. Ashley Breakdown of academic impact, for papers by Arwa Qaqish Breakdown of academic impact, for papers by Ane Ogbe Breakdown of academic impact, for papers by Henry J. Sutton Breakdown of academic impact, for papers by Stella E. van Trierum Breakdown of academic impact, for papers by Rafi Ahmed Breakdown of academic impact, for papers by Ludivine Grzelak Breakdown of academic impact, for papers by Dennis Lapuente
Rankless by CCL
2026